Accessibility Menu
 
Oculis Ag logo

Oculis Ag

(NASDAQ) OCS

Current Price$24.86
Market Cap$1.42B
Since IPO (2021)+156%
5 YearN/A
1 Year+27%
1 Month-13%

Oculis Ag Financials at a Glance

Market Cap

$1.42B

Revenue (TTM)

$504.00K

Net Income (TTM)

$98.78M

EPS (TTM)

$-2.28

P/E Ratio

-10.90

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$24.86

Volume

282,053

Open

$25.49

Previous Close

$24.86

Daily Range

$24.54 - $26.01

52-Week Range

$14.00 - $30.68

OCS News

No articles available.

OCS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oculis Ag

Industry

Pharmaceuticals

Employees

60

CEO

Riad Sherif, MD, MBA

Headquarters

Zug, 6300, CH

OCS Financials

Key Financial Metrics (TTM)

Gross Margin

-29%

Operating Margin

-163%

Net Income Margin

-196%

Return on Equity

-72%

Return on Capital

-41%

Return on Assets

-42%

Earnings Yield

-9.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.42B

Shares Outstanding

57.17M

Volume

282.05K

Short Interest

0.00%

Avg. Volume

313.48K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$79.15M

EBITDA

$79.15M

Operating Cash Flow

$62.22M

Capital Expenditure

$287.47K

Free Cash Flow

$62.51M

Cash & ST Invst.

$213.25M

Total Debt

$2.32M

Oculis Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.42B

N/A

Market Cap/Employee

$29.00M

N/A

Employees

49

N/A

Net Income

$23.34M

+18.6%

EBITDA

$20.88M

+26.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$210.94M

+116.4%

Accounts Receivable

$994.13K

+27.9%

Inventory

$0.00

N/A

Long Term Debt

$1.81M

+109.6%

Short Term Debt

$502.57K

+59.5%

Return on Assets

-41.81%

N/A

Return on Invested Capital

-41.08%

N/A

Free Cash Flow

$16.02M

-53.8%

Operating Cash Flow

$15.98M

-54.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MNMDMind Medicine (MindMed) Inc.
$18.39-1.45%
NKTRNektar Therapeutics
$72.22-3.50%
NRIXNurix Therapeutics, Inc.
$14.43-3.28%
KODKodiak Sciences Inc.
$22.25-1.83%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About OCS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.